Report Overview
The Live Cell Encapsulation market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Live Cell Encapsulation market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Live Cell Encapsulation companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Viacyte, Inc.
Living Cell Technologies Ltd.
Sigilon Therapeutics, Inc
Sernova Corporation
PharmaCyte Biotech Inc
Gloriana Therapeutics
Kadimastem
Beta-O2 Technologies, Inc.
Altucell, Inc.
Diatranz Otsuka Ltd
Product Type Insights
Global markets are presented by Live Cell Encapsulation type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Live Cell Encapsulation are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Live Cell Encapsulation segment by Type
Alginate
Chitosan
Cellulose
Others
Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Live Cell Encapsulation market and what implications these may have on the industrys future. This report can help to understand the relevant market and consumer trends that are driving the Live Cell Encapsulation market.
Live Cell Encapsulation Segment by Application
Diabetes
Cancer
Epilepsy
Parkinson
Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Live Cell Encapsulation market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Live Cell Encapsulation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Live Cell Encapsulation and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Live Cell Encapsulation industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Live Cell Encapsulation.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Live Cell Encapsulation companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Table of Contents
- 1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
- 2 Market Overview
- 2.1 Product Definition
- 2.2 Live Cell Encapsulation by Type
- 2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
- 1.2.2 Alginate
- 1.2.3 Chitosan
- 1.2.4 Cellulose
- 1.2.5 Others
- 2.3 Live Cell Encapsulation by Application
- 2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
- 2.3.2 Diabetes
- 2.3.3 Cancer
- 2.3.4 Epilepsy
- 2.3.5 Parkinson
- 2.3.6 Others
- 2.4 Assumptions and Limitations
- 3 Live Cell Encapsulation Breakdown Data by Type
- 3.1 Global Live Cell Encapsulation Historic Market Size by Type (2018-2023)
- 3.2 Global Live Cell Encapsulation Forecasted Market Size by Type (2023-2028)
- 4 Live Cell Encapsulation Breakdown Data by Application
- 4.1 Global Live Cell Encapsulation Historic Market Size by Application (2018-2023)
- 4.2 Global Live Cell Encapsulation Forecasted Market Size by Application (2018-2023)
- 5 Global Growth Trends
- 5.1 Global Live Cell Encapsulation Market Perspective (2018-2029)
- 5.2 Global Live Cell Encapsulation Growth Trends by Region
- 5.2.1 Global Live Cell Encapsulation Market Size by Region: 2018 VS 2022 VS 2029
- 5.2.2 Live Cell Encapsulation Historic Market Size by Region (2018-2023)
- 5.2.3 Live Cell Encapsulation Forecasted Market Size by Region (2024-2029)
- 5.3 Live Cell Encapsulation Market Dynamics
- 5.3.1 Live Cell Encapsulation Industry Trends
- 5.3.2 Live Cell Encapsulation Market Drivers
- 5.3.3 Live Cell Encapsulation Market Challenges
- 5.3.4 Live Cell Encapsulation Market Restraints
- 6 Market Competitive Landscape by Players
- 6.1 Global Top Live Cell Encapsulation Players by Revenue
- 6.1.1 Global Top Live Cell Encapsulation Players by Revenue (2018-2023)
- 6.1.2 Global Live Cell Encapsulation Revenue Market Share by Players (2018-2023)
- 6.2 Global Live Cell Encapsulation Industry Players Ranking, 2021 VS 2022 VS 2023
- 6.3 Global Key Players of Live Cell Encapsulation Head office and Area Served
- 6.4 Global Live Cell Encapsulation Players, Product Type & Application
- 6.5 Global Live Cell Encapsulation Players, Date of Enter into This Industry
- 6.6 Global Live Cell Encapsulation Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
- 6.1 Global Top Live Cell Encapsulation Players by Revenue
- 7 North America
- 7.1 North America Live Cell Encapsulation Market Size (2018-2029)
- 7.2 North America Live Cell Encapsulation Market Growth Rate by Country: 2018 VS 2022 VS 2029
- 7.3 North America Live Cell Encapsulation Market Size by Country (2018-2023)
- 7.4 North America Live Cell Encapsulation Market Size by Country (2024-2029)
- 7.5 United States
- 7.6 Canada
- 8 Europe
- 8.1 Europe Live Cell Encapsulation Market Size (2018-2029)
- 8.2 Europe Live Cell Encapsulation Market Growth Rate by Country: 2018 VS 2022 VS 2029
- 8.3 Europe Live Cell Encapsulation Market Size by Country (2018-2023)
- 8.4 Europe Live Cell Encapsulation Market Size by Country (2024-2029)
- 7.4 Germany
- 7.5 France
- 7.6 U.K.
- 7.7 Italy
- 7.8 Russia
- 7.9 Nordic Countries
- 9 Asia-Pacific
- 9.1 Asia-Pacific Live Cell Encapsulation Market Size (2018-2029)
- 9.2 Asia-Pacific Live Cell Encapsulation Market Growth Rate by Country: 2018 VS 2022 VS 2029
- 9.3 Asia-Pacific Live Cell Encapsulation Market Size by Country (2018-2023)
- 9.4 Asia-Pacific Live Cell Encapsulation Market Size by Country (2024-2029)
- 8.4 China
- 8.5 Japan
- 8.6 South Korea
- 8.7 Southeast Asia
- 8.8 India
- 8.9 Australia
- 10 Latin America
- 10.1 Latin America Live Cell Encapsulation Market Size (2018-2029)
- 10.2 Latin America Live Cell Encapsulation Market Growth Rate by Country: 2018 VS 2022 VS 2029
- 10.3 Latin America Live Cell Encapsulation Market Size by Country (2018-2023)
- 10.4 Latin America Live Cell Encapsulation Market Size by Country (2024-2029)
- 9.4 Mexico
- 9.5 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Live Cell Encapsulation Market Size (2018-2029)
- 11.2 Middle East & Africa Live Cell Encapsulation Market Growth Rate by Country: 2018 VS 2022 VS 2029
- 11.3 Middle East & Africa Live Cell Encapsulation Market Size by Country (2018-2023)
- 11.4 Middle East & Africa Live Cell Encapsulation Market Size by Country (2024-2029)
- 10.4 Turkey
- 10.5 Saudi Arabia
- 10.6 UAE
- 12 Players Profiled
- 11.1 Viacyte, Inc.
- 11.1.1 Viacyte, Inc. Company Detail
- 11.1.2 Viacyte, Inc. Business Overview
- 11.1.3 Viacyte, Inc. Live Cell Encapsulation Introduction
- 11.1.4 Viacyte, Inc. Revenue in Live Cell Encapsulation Business (2017-2022)
- 11.1.5 Viacyte, Inc. Recent Development
- 11.2 Living Cell Technologies Ltd.
- 11.2.1 Living Cell Technologies Ltd. Company Detail
- 11.2.2 Living Cell Technologies Ltd. Business Overview
- 11.2.3 Living Cell Technologies Ltd. Live Cell Encapsulation Introduction
- 11.2.4 Living Cell Technologies Ltd. Revenue in Live Cell Encapsulation Business (2017-2022)
- 11.2.5 Living Cell Technologies Ltd. Recent Development
- 11.3 Sigilon Therapeutics, Inc
- 11.3.1 Sigilon Therapeutics, Inc Company Detail
- 11.3.2 Sigilon Therapeutics, Inc Business Overview
- 11.3.3 Sigilon Therapeutics, Inc Live Cell Encapsulation Introduction
- 11.3.4 Sigilon Therapeutics, Inc Revenue in Live Cell Encapsulation Business (2017-2022)
- 11.3.5 Sigilon Therapeutics, Inc Recent Development
- 11.4 Sernova Corporation
- 11.4.1 Sernova Corporation Company Detail
- 11.4.2 Sernova Corporation Business Overview
- 11.4.3 Sernova Corporation Live Cell Encapsulation Introduction
- 11.4.4 Sernova Corporation Revenue in Live Cell Encapsulation Business (2017-2022)
- 11.4.5 Sernova Corporation Recent Development
- 11.5 PharmaCyte Biotech Inc
- 11.5.1 PharmaCyte Biotech Inc Company Detail
- 11.5.2 PharmaCyte Biotech Inc Business Overview
- 11.5.3 PharmaCyte Biotech Inc Live Cell Encapsulation Introduction
- 11.5.4 PharmaCyte Biotech Inc Revenue in Live Cell Encapsulation Business (2017-2022)
- 11.5.5 PharmaCyte Biotech Inc Recent Development
- 11.6 Gloriana Therapeutics
- 11.6.1 Gloriana Therapeutics Company Detail
- 11.6.2 Gloriana Therapeutics Business Overview
- 11.6.3 Gloriana Therapeutics Live Cell Encapsulation Introduction
- 11.6.4 Gloriana Therapeutics Revenue in Live Cell Encapsulation Business (2017-2022)
- 11.6.5 Gloriana Therapeutics Recent Development
- 11.7 Kadimastem
- 11.7.1 Kadimastem Company Detail
- 11.7.2 Kadimastem Business Overview
- 11.7.3 Kadimastem Live Cell Encapsulation Introduction
- 11.7.4 Kadimastem Revenue in Live Cell Encapsulation Business (2017-2022)
- 11.7.5 Kadimastem Recent Development
- 11.8 Beta-O2 Technologies, Inc.
- 11.8.1 Beta-O2 Technologies, Inc. Company Detail
- 11.8.2 Beta-O2 Technologies, Inc. Business Overview
- 11.8.3 Beta-O2 Technologies, Inc. Live Cell Encapsulation Introduction
- 11.8.4 Beta-O2 Technologies, Inc. Revenue in Live Cell Encapsulation Business (2017-2022)
- 11.8.5 Beta-O2 Technologies, Inc. Recent Development
- 11.9 Altucell, Inc.
- 11.9.1 Altucell, Inc. Company Detail
- 11.9.2 Altucell, Inc. Business Overview
- 11.9.3 Altucell, Inc. Live Cell Encapsulation Introduction
- 11.9.4 Altucell, Inc. Revenue in Live Cell Encapsulation Business (2017-2022)
- 11.9.5 Altucell, Inc. Recent Development
- 11.10 Diatranz Otsuka Ltd
- 11.10.1 Diatranz Otsuka Ltd Company Detail
- 11.10.2 Diatranz Otsuka Ltd Business Overview
- 11.10.3 Diatranz Otsuka Ltd Live Cell Encapsulation Introduction
- 11.10.4 Diatranz Otsuka Ltd Revenue in Live Cell Encapsulation Business (2017-2022)
- 11.10.5 Diatranz Otsuka Ltd Recent Development
- 11.1 Viacyte, Inc.
- 13 Report Conclusion
- 14 Disclaimer